RightFit
RecruitingPhase not listed

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Male only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Urine samples, Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer."
  • "Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study collects samples, such as blood, urine, and tissue, and health information to learn more about advanced prostate cancer. It is for men whose prostate cancer has spread and who are about to start a new treatment that works throughout the body. Researchers hope to find ways to improve care in the future.

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Men age 18 or older, of any race or ethnic group.
  • Have prostate cancer that has spread to other parts of the body.
  • Are scheduled to start a new treatment that works throughout the body. This can be the first treatment or a later one.
  • Past participation in other clinical trials is allowed.

Who can't join

  • Cannot give informed consent, meaning you cannot understand the study and agree to join.
  • Have another cancer, unless it was treated with the goal of curing it and you have been free of that cancer for at least 3 years.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Men of all racial and ethnic groups 18 years of age or older * Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy) * Prior participation on clinical trials is allowed Exclusion Criteria: * Inability to give informed consent * Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer

Study sites (2)

CA